Esketamine

INDICATIONS

FDA

  • Treatment-resistant depression as monotherapy or adjunct to antidepressant therapy
  • MDD with acute suicidal ideation as adjunct to antidepressant therapy

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: August 30, 2025